An observational study in Bladder Cancer, Prostate Cancer and Renal Cancer, sponsored by Jagiellonian University. Recruiting at 1 site in Poland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-03.
Sponsored by Jagiellonian University · Observational
This study will examine the work status of all adult patients admitted over a 6-month period to the University Hospital in Kraków, Poland, for treatment of urological diseases. All admitted patients will be surveyed about their job situation. Patients who are occupationally active and undergoing major oncological surgeries (such as radical cystectomy, prostatectomy, or nephrectomy) or procedures for urinary tract stones will also complete a quality-of-life questionnaire and be followed up by phone at 3 and 6 months. The goal is to learn how treatment affects patients' ability to return to work and their well-being, to help guide support and rehabilitation strategies.
1,798 studies on the registry are indexed under Urinary Bladder Neoplasms; 445 are open to participants now.
This study's planned enrollment of 2,000 is above the median of 200 across 410 observational studies indexed under Urinary Bladder Neoplasms.
Browse Urinary Bladder Neoplasms studies →Jagiellonian University is the lead sponsor of 161 studies on the registry; 35 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Consecutive adult patients admitted over a 6-month period to the Department of Urology and Oncological Urology at the University Hospital in Kraków, an academic tertiary care center in Poland. As this is a uro-oncological department, patients with urological cancers are likely to be overrepresented. The population includes individuals hospitalized for a range of urological diseases, with a subset of occupationally active patients undergoing major uro-oncological surgeries or procedures for urinary tract stones. Participants represent a typical tertiary referral population treated for both malignant and benign urological conditions.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
For the prospective follow-up cohort:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adult patients (≥18 years) admitted over a 6-month period to the Department of Urology and Oncological Urology, University Hospital in Kraków, Poland, including a subset of occupationally active individuals undergoing major uro-oncological surgeries or procedures for urinary tract stones.
Other: Occupational Status Survey and Telephone Follow-up and Quality-of-Life Assessment in a subset of patients
Collection of demographic, employment, and clinical data at hospital admission, with additional EQ-5D-5L quality-of-life questionnaire and telephone follow-up for occupationally active patients undergoing major uro-oncological surgeries or urinary tract stone procedures.
Occupational Status of Patients With Urological Diseases
Descriptive assessment of employment categories (employed, unemployed, on disability, retired) among all admitted patients, and changes in employment status over time for occupationally active patients undergoing major surgeries or stone-related procedures.
Time frame: At hospital admission (baseline), and at 3 and 6 months for the prospective cohort
Return to Work Rate in Occupationally Active Patients Undergoing Major Uro-Oncological Surgeries
Proportion of employed patients at baseline who resume or maintain work following radical cystectomy, radical prostatectomy, radical or partial nephrectomy, or nephroureterectomy.
Time frame: 3 months and 6 months after surgery
Return to Work Rate in Occupationally Active Patients Undergoing Procedures for Urinary Tract Stones
Proportion of employed patients at baseline who resume or maintain work following ureterorenoscopy or percutaneous nephrolithotripsy.
Time frame: 3 months and 6 months after procedure
Change in Quality of Life in Occupationally Active Patients Undergoing Major Uro-Oncological Surgeries (EQ-5D-5L Score)
Time frame: Baseline, 3 months, and 6 months
Change in Quality of Life in Occupationally Active Patients Undergoing Procedures for Urinary Tract Stones (EQ-5D-5L Score)
Time frame: Baseline, 3 months, and 6 months
Plan to share: Undecided
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.